Charles Calderaro's most recent trade in Avidity Biosciences Inc was a trade of 98,547 Common Stock done . Disclosure was reported to the exchange on Feb. 27, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avidity Biosciences Inc | Charles Calderaro | Chief Technical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Feb 2026 | 98,547 | 0 | - | - | Common Stock | |
| Avidity Biosciences Inc | Charles Calderaro | Chief Technical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Feb 2026 | 80,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Charles Calderaro | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 72.23 per share. | 07 Jan 2026 | 3,727 | 49,797 | - | 72.2 | 269,201 | Common Stock |
| Avidity Biosciences Inc | Charles Calderaro | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 23,250 | 63,250 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | Charles Calderaro | Chief Technical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.87 per share. | 17 Dec 2025 | 9,726 | 53,524 | - | 71.9 | 699,008 | Common Stock |
| Avidity Biosciences Inc | Charles Calderaro | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Charles Calderaro | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 40,000 | 40,000 | - | 0 | Common Stock |